Is Chimera Investment (CIM) Outperforming Other Finance Stocks This Year?

CIM

Investors focused on the Finance space have likely heard of Chimera Investment (CIM - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.

Chimera Investment is a member of the Finance sector. This group includes 848 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CIM is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for CIM's full-year earnings has moved 2.36% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, CIM has returned 8.81% so far this year. Meanwhile, the Finance sector has returned an average of 8.27% on a year-to-date basis. This means that Chimera Investment is outperforming the sector as a whole this year.

Looking more specifically, CIM belongs to the REIT and Equity Trust industry, a group that includes 29 individual stocks and currently sits at #25 in the Zacks Industry Rank. This group has gained an average of 9.03% so far this year, so CIM is slightly underperforming its industry in this area.

Going forward, investors interested in Finance stocks should continue to pay close attention to CIM as it looks to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>